I don't really understand the selling as I'm not sure that any of the announces have had an impact. You would think they would have mitigated the fall, but the selling has been relentless.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling